Clinical Trials
Pharmacist review improves medication quality in older cancer patients, trial finds
Degen et alJournal of Internal Medicine

In a multicenter, single-blinded randomized controlled trial conducted across ten rehabilitation clinics in Germany, investigators evaluated whether a comprehensive pharmacist-led medication review utilizing the validated Fit fOR The Aged (FORTA) list improves medication quality compared with usual care in older cancer patients with polypharmacy. The trial enrolled 443 patients aged 65 years and older with common cancers who were regularly taking at least five medications. The FORTA scoring system quantifies medication appropriateness by weighting potentially inappropriate medications (PIMs; two points each), drug underuse (one point each), and drug overuse (one point each).
Baseline intention-to-treat analyses revealed extensive medication mismanagement on admission: 66.1% of patients were exposed to PIMs, 94.6% had medication underuse, and 58.9% had medication overuse, yielding a baseline median FORTA score of 6. At discharge, patients in the pharmacist-led intervention arm (n = 234) experienced a statistically significant reduction in mean FORTA score relative to the usual care arm (n = 209), with an adjusted mean difference of -3.7 points (95% CI: -4.2 to -3.3).
Additionally, the intervention achieved marked reductions in the proportion of patients subject to inappropriate prescribing patterns, lowering PIM exposure by 41.3 percentage points, underuse by 35.5 percentage points, and overuse by 30.7 percentage points (all p < 0.001). Clinically, this reduction of approximately four FORTA points corresponds to the cessation of two PIMs or the discontinuation of four overused medications, confirming the utility of structured pharmacist reviews for optimizing geriatric oncologic pharmacotherapy.
Key Takeaways
- A pharmacist-led medication review using the FORTA list resulted in a statistically significant greater reduction in mean FORTA score compared with usual care from admission to discharge (mean difference: -3.7 points; 95% CI: -4.2 to -3.3).
- The FORTA-based intervention statistically significantly decreased the proportions of older cancer patients affected by potentially inappropriate medications, drug underuse, and drug overuse by 41.3, 35.5, and 30.7 percentage points, respectively (all p < 0.001).
Read the original sourceJournal of Internal Medicine
